autologous kras g12d-specific hla-c*08:02-restricted tcr gene engineered t-lymphocytes nt-112

Generic: Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR Gene Engineered T-lymphocytes NT-112

Get deeper analysis on autologous kras g12d-specific hla-c*08:02-restricted tcr gene engineered t-lymphocytes nt-112

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    autologous kras g12d-specific hla-c*08:02-restricted tcr gene engineered t-lymphocytes nt-112 — Drug Pipeline, Trials & FDA Status | BioSniper